{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:21:34Z","timestamp":1793924494541,"version":"4.8.0"},"reference-count":96,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["COS"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Heterocyclic compounds are a class of compounds that is deeply intertwined with biological\nprocesses and is found in about 90% of commercially available medicines. They serve a\ncritical function in medicinal chemistry and are focused in the field of medication development for\ntheir intensive research due to their broad variety of biological effects because of their intriguing\nmolecular architecture, such as indoles are good candidates for drug development. It is a bicyclic\nstructure consisting of a six-membered benzene ring fused to a five-membered pyrrole ring with\nseveral pharmacophores that yield a library of different lead compounds. Human cancer cells have\nbeen demonstrated to be inhibited by indoles in the development of new anticancer medicines.\nThis is the first comprehensive review to focus on current methodologies for incorporating indole\nmoiety, with their mechanistic targets as anticancer drugs, in order to shed light on the logical development\nof indole-based anticancer treatment options with high efficacy. This compiled data\nmay serve as a benchmark for modifying existing ligands in order to design novel potent molecules\nthrough excellent yield synthesis techniques.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1570179419666220509215722","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T03:03:02Z","timestamp":1652238182000},"page":"376-394","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Recent Developments in the Synthesis and Anticancer Activity of Indole\nand Its Derivatives"],"prefix":"10.2174","volume":"20","author":[{"given":"Pankaj","family":"Wadhwa","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balwinder","family":"Kaur","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Venugopal","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Verma","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev Kumar","family":"Sahu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of\nChemistry, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, Punjab, 144401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of\nChemistry, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara, Punjab, 144401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"Siegel R.L.","year":"2015","unstructured":"Siegel R.L.; Miller K.D.; Jemal A.; Cancer statistics, 2015. CA Cancer J Clin 2015,65(1),5-29","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","volume":"93","author":"P&#xE9;rez-Herrero E.","year":"2015","unstructured":"P&#xE9;rez-Herrero E.; Fern&#xE1;ndez-Medarde A.; Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 2015,93,52-79","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1007\/s11095-010-0154-2","volume":"27","author":"Koning G.A.","year":"2010","unstructured":"Koning G.A.; Eggermont A.M.; Lindner L.H.; ten Hagen T.L.; Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm Res 2010,27(8),1750-1754","journal-title":"Pharm Res"},{"key":"ref=4","first-page":"400","volume":"2","author":"Mohamed N.R.","year":"2010","unstructured":"Mohamed N.R.; Khaireldin N.Y.; Fahmyb A.; El-Sayeda A.; Facile synthesis of fused nitrogen containing heterocycles as anticancer agents. Pharma Chem 2010,2,400-417","journal-title":"Pharma Chem"},{"key":"ref=5","first-page":"1","volume":"5","author":"Biswal S.","year":"2012","unstructured":"Biswal S.; Sahoo U.; Sethy S.; Kumar H.; Banerjee M.; Indole: The molecule of diverse biological activities. Asian J Pharm Clin Res 2012,5(1),1-6","journal-title":"Asian J Pharm Clin Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"104026","DOI":"10.1016\/j.bioorg.2020.104026","volume":"101","author":"Archna Pathania","year":"2020","unstructured":"Archna Pathania; S.; Chawla, P.A. Thiophene-based derivatives as anticancer agents: An overview on decade\u2019s work. Bioorg Chem 2020,101,104026","journal-title":"Bioorg Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ejmech.2019.07.019","volume":"180","author":"Garg V.","year":"2019","unstructured":"Garg V.; Maurya R.K.; Thanikachalam P.V.; Bansal G.; Monga V.; An insight into the medicinal perspective of synthetic analogs of indole: A review. Eur J Med Chem 2019,180,562-612","journal-title":"Eur J Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.1016\/j.bmc.2013.07.028","volume":"21","author":"Macdonough M.T.","year":"2013","unstructured":"Macdonough M.T.; Strecker T.E.; Hamel E.; Hall J.J.; Chaplin D.J.; Trawick M.L.; Pinney K.G.; Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3\u2032-hydroxy-4\u2032-methoxyphenyl)-3-(3\u2033,4\u2033,5\u2033-trimethoxybenzoyl)-6-methoxyindole (OXi8006). Bioorg Med Chem 2013,21(21),6831-6843","journal-title":"Bioorg Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/ajoc.202100280","volume":"10","author":"Wang Z.Y.","year":"2021","unstructured":"Wang Z.Y.; Xu S.; Wang K.K.; Kong N.; Liu X.; Recent studies of bifunctionalization of simple indoles. Asian J Org Chem 2021,10(7),1580-1594","journal-title":"Asian J Org Chem"},{"key":"ref=10","first-page":"141","volume":"9","author":"Al-Mulla A.","year":"2017","unstructured":"Al-Mulla A.; A review: Biological importance of heterocyclic compounds. Pharma Chem 2017,9(13),141-147","journal-title":"Pharma Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jss.2016.04.021","volume":"204","author":"Megna B.W.","year":"2016","unstructured":"Megna B.W.; Carney P.R.; Nukaya M.; Geiger P.; Kennedy G.D.; Indole-3-carbinol induces tumor cell death: Function follows form. J Surg Res 2016,204(1),47-54","journal-title":"J Surg Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ejmech.2014.11.007","volume":"97","author":"Sherer C.","year":"2015","unstructured":"Sherer C.; Snape T.J.; Heterocyclic scaffolds as promising anticancer agents against tumours of the central nervous system: Exploring the scope of indole and carbazole derivatives. Eur J Med Chem 2015,97,552-560","journal-title":"Eur J Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"37905","DOI":"10.1039\/C8RA07060A","volume":"8","author":"Ali I.","year":"2018","unstructured":"Ali I.; Mukhtar S.D.; Hsieh M.F.; Alothman Z.A.; Alwarthan A.; Facile synthesis of indole heterocyclic compounds based micellar nano anti-cancer drugs. RSC Advances 2018,8(66),37905-37914","journal-title":"RSC Advances"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.tetlet.2013.12.050","volume":"55","author":"Dulla B.","year":"2014","unstructured":"Dulla B.; Sailaja E.; CH, U.R.; Aeluri, M.; Kalle, M.; Bhavani, S.; Rambabu, D.; Rao, M.B.; Pal, M. Synthesis of indole based novel small molecules and their in vitro anti-proliferative effects on various cancer cell lines. Tetrahedron Lett 2014,55(4),921-926","journal-title":"Tetrahedron Lett"},{"key":"ref=15","doi-asserted-by":"publisher","DOI":"10.1002\/9781118686263","author":"Yet L.","year":"2018","unstructured":"Yet L.;  Privileged structures in drug discovery: Medicinal chemistry and synthesis 2018","journal-title":"Privileged structures in drug discovery: Medicinal chemistry and synthesis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1039\/C7CS00508C","volume":"47","author":"Bariwal J.","year":"2018","unstructured":"Bariwal J.; Voskressensky L.G.; Van der Eycken E.V.; Recent advances in spirocyclization of indole derivatives. Chem Soc Rev 2018,47(11),3831-3848","journal-title":"Chem Soc Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.bioorg.2018.05.004","volume":"79","author":"Islam M.S.","year":"2018","unstructured":"Islam M.S.; Barakat A.; Al-Majid A.M.; Ali M.; Yousuf S.; Iqbal Choudhary M.; Khalil R.; Ul-Haq Z.; Catalytic asymmetric synthesis of indole derivatives as novel &#x3B1;-glucosidase inhibitors in vitro. Bioorg Chem 2018,79,350-354","journal-title":"Bioorg Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1002\/adsc.201901520","volume":"362","author":"Yu Y.","year":"2020","unstructured":"Yu Y.; Zhong J.S.; Xu K.; Yuan Y.; Ye K.Y.; Recent advances in the electrochemical synthesis and functionalization of indole derivatives. Adv Synth Catal 2020,362(11),2102-2119","journal-title":"Adv Synth Catal"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.gresc.2021.02.001","volume":"2","author":"Rago A.J.","year":"2021","unstructured":"Rago A.J.; Dong G.; Synthesis of indoles, indolines, and carbazoles via palladium-catalyzed C\u2013H activation. Green Synthesis Catalysis 2021,2(2),216-227","journal-title":"Green Synthesis Catalysis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"103021","DOI":"10.1016\/j.bioorg.2019.103021","volume":"89","author":"Kumari A.","year":"2019","unstructured":"Kumari A.; Singh R.K.; Medicinal chemistry of indole derivatives: Current to future therapeutic prospectives. Bioorg Chem 2019,89,103021","journal-title":"Bioorg Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"13185","DOI":"10.1039\/D0CC03258A","volume":"56","author":"&#xD6;zkaya B.","year":"2020","unstructured":"&#xD6;zkaya B.; Bub C.L.; Patureau F.W.; Step and redox efficient nitroarene to indole synthesis. Chem Commun (Camb) 2020,56(86),13185-13188","journal-title":"Chem Commun (Camb)"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.1021\/acs.joc.1c00988","volume":"86","author":"Zheng Y-T.","year":"2021","unstructured":"Zheng Y-T.; Song J.; Xu H-C.; Electrocatalytic dehydrogenative cyclization of 2-vinylanilides for the synthesis of indoles. J Org Chem 2021,86(22),16001-16007","journal-title":"J Org Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"9272","DOI":"10.1002\/chem.202100829","volume":"27","author":"Yang W.","year":"2021","unstructured":"Yang W.; Dong P.; Xu J.; Yang J.; Liu X.; Feng X.; Enantioselective synthesis of 3-substituted 3-amino-2-oxindoles by amination with anilines. Chemistry 2021,27(36),9272-9275","journal-title":"Chemistry"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.1021\/acs.orglett.7b02244","volume":"19","author":"Zeidan N.","year":"2017","unstructured":"Zeidan N.; Bognar S.; Lee S.; Lautens M.; Palladium-Catalyzed synthesis of 2-cyanoindoles from 2-gem-dihalovinylanilines. Org Lett 2017,19(19),5058-5061","journal-title":"Org Lett"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1021\/acs.joc.7b00148","volume":"82","author":"Yu S.","year":"2017","unstructured":"Yu S.; Qi L.; Hu K.; Gong J.; Cheng T.; Wang Q.; Chen J.; Wu H.; The development of a palladium-catalyzed tandem addition\/cyclization for the construction of indole skeletons. J Org Chem 2017,82(7),3631-3638","journal-title":"J Org Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1021\/acs.orglett.7b02230","volume":"19","author":"Vickerman K.L.","year":"2017","unstructured":"Vickerman K.L.; Stanley L.M.; Catalytic, enantioselective synthesis of polycyclic nitrogen, oxygen, and sulfur heterocycles via Rh-catalyzed alkene hydroacylation. Org Lett 2017,19(19),5054-5057","journal-title":"Org Lett"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"4359-4362","DOI":"10.1021\/acs.orglett.7b02066","volume":"19","author":"Shi P.","year":"2017","unstructured":"Shi P.; Wang L.; Guo S.; Chen K.; Wang J.; Zhu J.; A C-H activation-based strategy for N-Amino azaheterocycle synthesis. Org Lett 2017,19(16),4359-4362","journal-title":"Org Lett"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1021\/acs.orglett.6b00689","volume":"18","author":"Hu Z.","year":"2016","unstructured":"Hu Z.; Tong X.; Liu G.; Rhodium(III)-catalyzed cascade cyclization\/Electrophilic amidation for the synthesis of 3-amidoindoles and 3-amidofurans. Org Lett 2016,18(9),2058-2061","journal-title":"Org Lett"},{"key":"ref=29","author":"Sosoe J.","year":"2020","unstructured":"Sosoe J.; Synth&#xE8;se, caract&#xE9;risation et &#xE9;valuation des performances de photosensibilisateurs &#xE0; base de cuivre en synth&#xE8;se organique. 2020"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"13264","DOI":"10.1002\/anie.201405478","volume":"53","author":"Zoller J.","year":"2014","unstructured":"Zoller J.; Fabry D.C.; Ronge M.A.; Rueping M.; Synthesis of indoles using visible light: Photoredox catalysis for palladium-catalyzed C-H activation. Angew Chem Int Ed Engl 2014,53(48),13264-13268","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"6810","DOI":"10.1021\/acs.orglett.0c02323","volume":"22","author":"Jia R.","year":"2020","unstructured":"Jia R.; Li B.; Zhang X.; Fan X.; Selective synthesis of 2-indolyl-3-oxoindolines or 2-(2-aminophenyl) quinolines through Cu (II)-or Bi (III)-catalyzed tunable dimerizations of 2-alkynylanilines. Org Lett 2020,22(17),6810-6815","journal-title":"Org Lett"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/nsr\/nwy034","volume":"5","author":"Yan J.","year":"2018","unstructured":"Yan J.; Zhang J.; Chen X.; Malola S.; Zhou B.; Selenius E.; Zhang X.; Yuan P.; Deng G.; Liu K.; Thiol-stabilized atomically precise, superatomic silver nanoparticles for catalysing cycloisomerization of alkynyl amines. Natl Sci Rev 2018,5(5),694-702","journal-title":"Natl Sci Rev"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1021\/acs.orglett.6b00884","volume":"18","author":"Miao B.","year":"2016","unstructured":"Miao B.; Li S.; Li G.; Ma S.; Cyclic anti-azacarboxylation of 2-alkynylanilines with carbon dioxide. Org Lett 2016,18(11),2556-2559","journal-title":"Org Lett"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ijch.201300040","volume":"53","author":"Abbiati G.","year":"2013","unstructured":"Abbiati G.; Marinelli F.; Rossi E.; Arcadi A.; synthesis of indole derivatives from 2\u2010alkynylanilines by means of gold catalysis. Isr J Chem 2013,53(11\u201012),856-868","journal-title":"Isr J Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"104705","DOI":"10.1016\/j.bioorg.2021.104705","volume":"109","author":"Wang W-Y.","year":"2021","unstructured":"Wang W-Y.; Wu W-Y.; Li A-L.; Liu Q-S.; Sun Y.; Gu W.; Synthesis, anticancer evaluation and mechanism studies of novel indolequinone derivatives of ursolic acid. Bioorg Chem 2021,109,104705","journal-title":"Bioorg Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.3390\/ijms21082876","volume":"21","author":"Li A.L.","year":"2020","unstructured":"Li A.L.; Hao Y.; Wang W-Y.; Liu Q-S.; Sun Y.; Gu W.; Design, synthesis, and anticancer evaluation of novel indole derivatives of ursolic acid as potential topoisomerase II inhibitors. Int J Mol Sci 2020,21(8),2876","journal-title":"Int J Mol Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.tet.2009.10.091","volume":"66","author":"Wang L-M.","year":"2010","unstructured":"Wang L-M.; Jiao N.; Qiu J.; Yu J-J.; Liu J-Q.; Guo F-L.; Liu Y.; Sodium stearate-catalyzed multicomponent reactions for efficient synthesis of spirooxindoles in aqueous micellar media. Tetrahedron 2010,66(1),339-343","journal-title":"Tetrahedron"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1016\/j.tetlet.2012.09.013","volume":"53","author":"Jain R.","year":"2012","unstructured":"Jain R.; Sharma K.; Kumar D.; A greener, facile and scalable synthesis of indole derivatives in water: Reactions of indole-2, 3-diones with 1, 2-difunctionalized benzene. Tetrahedron Lett 2012,53(46),6236-6240","journal-title":"Tetrahedron Lett"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1007\/s11164-019-03831-2","volume":"45","author":"Nikoofar K.","year":"2019","unstructured":"Nikoofar K.; Peyrovebaghi S.S.; 1-Butyl-2-methylpipyridinium iodide ([BMPPY] I): Novel ionic liquid for the synthesis of 6-hydroxy-6-(1H-indol-3-yl) indolo [2, 1-b] quinazolin-12 (6H)-ones under green solvent-free conditions. Res Chem Intermed 2019,45(9),4287-4298","journal-title":"Res Chem Intermed"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10593-018-2313-z","volume":"54","author":"Sheikholeslami-Farahani F.","year":"2018","unstructured":"Sheikholeslami-Farahani F.; Karami H.; Salimifard M.; Abad S.A.S.; Eslami A.A.; ZnO nanorod-catalyzed three-component reaction of euparin, aldehyde, and dialkyl acetylenedicarboxylate: Green synthesis of chromene derivatives. Chem Heterocycl Compd 2018,54(6),593-597","journal-title":"Chem Heterocycl Compd"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10593-015-1734-1","volume":"51","author":"Sayyed-Alangi S.Z.","year":"2015","unstructured":"Sayyed-Alangi S.Z.; Hossaini Z.; ZnO nanorods as an efficient catalyst for the green synthesis of indole derivatives using isatoic anhydride. Chem Heterocycl Compd 2015,51(6),541-544","journal-title":"Chem Heterocycl Compd"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.1016\/j.tetlet.2014.07.113","volume":"55","author":"Abe T.","year":"2014","unstructured":"Abe T.; Itoh T.; Choshi T.; Hibino S.; Ishikura M.; One-pot synthesis of tryptanthrin by the Dakin oxidation of indole-3-carbaldehyde. Tetrahedron Lett 2014,55(38),5268-5270","journal-title":"Tetrahedron Lett"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1055\/s-0037-1609733","volume":"50","author":"Kumar I.","year":"2018","unstructured":"Kumar I.; Kumar R.; Sharma U.; Recent advances in the regioselective synthesis of indoles via c\u2013h activation\/functionalization. Synthesis 2018,50(14),2655-2677","journal-title":"Synthesis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"17049","DOI":"10.1002\/anie.202006137","volume":"59","author":"Li X.","year":"2020","unstructured":"Li X.; Sun J.; Organocatalytic enantioselective synthesis of chiral allenes: remote asymmetric 1,8-addition of indole imine methides. Angew Chem Int Ed Engl 2020,59(39),17049-17054","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"9521","DOI":"10.1021\/acs.joc.6b01758","volume":"81","author":"Anderson L.L.","year":"2016","unstructured":"Anderson L.L.; Kroc M.A.; Reidl T.W.; Son J.; Cascade reactions of nitrones and allenes for the synthesis of indole derivatives. J Org Chem 2016,81(20),9521-9529","journal-title":"J Org Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tetasy.2013.11.018","volume":"25","author":"Islam M.S.","year":"2014","unstructured":"Islam M.S.; Al Majid A.M.; Al-Othman Z.A.; Barakat A.; Highly enantioselective Friedel\u2013Crafts alkylation of indole with electron deficient trans-&#x3B2;-nitroalkenes using Zn (II)\u2013oxazoline\u2013imidazoline catalysts. Tetrahedron Asymmetry 2014,25(3),245-251","journal-title":"Tetrahedron Asymmetry"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1016\/j.tet.2013.04.063","volume":"69","author":"Barakat A.","year":"2013","unstructured":"Barakat A.; Islam M.S.; Al Majid A.M.; Al-Othman Z.A.; Highly enantioselective Friedel\u2013Crafts alkylation of indoles with &#x3B1;, &#x3B2;-unsaturated ketones with simple Cu (II)\u2013oxazoline\u2013imidazoline catalysts. Tetrahedron 2013,69(25),5185-5192","journal-title":"Tetrahedron"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"7969","DOI":"10.1038\/s41598-020-64729-3","volume":"10","author":"Taha M.","year":"2020","unstructured":"Taha M.; Rahim F.; Khan A.A.; Anouar E.H.; Ahmed N.; Shah S.A.A.; Ibrahim M.; Zakari Z.A.; Synthesis of diindolylmethane (DIM) bearing thiadiazole derivatives as a potent urease inhibitor. Sci Rep 2020,10(1),7969","journal-title":"Sci Rep"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bioorg.2015.06.006","volume":"62","author":"Rahim F.","year":"2015","unstructured":"Rahim F.; Ullah H.; Javid M.T.; Wadood A.; Taha M.; Ashraf M.; Shaukat A.; Junaid M.; Hussain S.; Rehman W.; Mehmood R.; Sajid M.; Khan M.N.; Khan K.M.; Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of &#x3B1;-glucosidase. Bioorg Chem 2015,62,15-21","journal-title":"Bioorg Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.molstruc.2017.10.025","volume":"1153","author":"Almutairi M.S.","year":"2018","unstructured":"Almutairi M.S.; Zakaria A.S.; Ignasius P.P.; Al-Wabli R.I.; Joe I.H.; Attia M.I.; Synthesis, spectroscopic investigations, DFT studies, molecular docking and antimicrobial potential of certain new indole-isatin molecular hybrids: Experimental and theoretical approaches. J Mol Struct 2018,1153,333-345","journal-title":"J Mol Struct"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bioorg.2017.05.005","volume":"72","author":"Baharudin M.S.","year":"2017","unstructured":"Baharudin M.S.; Taha M.; Imran S.; Ismail N.H.; Rahim F.; Javid M.T.; Khan K.M.; Ali M.; Synthesis of indole analogs as potent &#x3B2;-glucuronidase inhibitors. Bioorg Chem 2017,72,323-332","journal-title":"Bioorg Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"e2000059","DOI":"10.1002\/ardp.202000059","volume":"353","author":"Kilic-Kurt Z.","year":"2020","unstructured":"Kilic-Kurt Z.; Acar C.; Ergul M.; Bakar-Ates F.; Altuntas T.G.; Novel indole hydrazide derivatives: Synthesis and their antiproliferative activities through inducing apoptosis and DNA damage. Arch Pharm (Weinheim) 2020,353(8),e2000059","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ejmech.2017.05.012","volume":"136","author":"Lafayette E.A.","year":"2017","unstructured":"Lafayette E.A.; de Almeida S.M.V.; Cavalcanti Santos R.V.; de Oliveira J.F.; Amorim C.A.D.C.; da Silva R.M.F.; Pitta M.G.D.R.; Pitta I.D.R.; de Moura R.O.; de Carvalho J&#xFA;nior L.B.; de Melo R&#xEA;go M.J.B.; de Lima M.D.C.A.; Synthesis of novel indole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I activities. Eur J Med Chem 2017,136,511-522","journal-title":"Eur J Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"e1800470","DOI":"10.1002\/cbdv.201800470","volume":"16","author":"Bakherad Z.","year":"2019","unstructured":"Bakherad Z.; Safavi M.; Fassihi A.; Sadeghi-Aliabadi H.; Bakherad M.; Rastegar H.; Saeedi M.; Ghasemi J.B.; Saghaie L.; Mahdavi M.; design and synthesis of novel cytotoxic indole-thiosemicarbazone derivatives: biological evaluation and docking study. Chem Biodivers 2019,16(4),e1800470","journal-title":"Chem Biodivers"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1016\/j.bmcl.2013.02.090","volume":"23","author":"Karaaslan C.","year":"2013","unstructured":"Karaaslan C.; Kadri H.; Coban T.; Suzen S.; Westwell A.D.; Synthesis and antioxidant properties of substituted 2-phenyl-1H-indoles. Bioorg Med Chem Lett 2013,23(9),2671-2674","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"103745","DOI":"10.1016\/j.bioorg.2020.103745","volume":"98","author":"Taha M.","year":"2020","unstructured":"Taha M.; Aldhamin E.A.J.; Almandil N.B.; Anouar E.H.; Uddin N.; Alomari M.; Rahim F.; Adalat B.; Ibrahim M.; Nawaz F.; Iqbal N.; Alghanem B.; Altolayyan A.; Khan K.M.; Synthesis of indole based acetohydrazide analogs: Their in vitro and in silico thymidine phosphorylase studies. Bioorg Chem 2020,98,103745","journal-title":"Bioorg Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e0181241","DOI":"10.1371\/journal.pone.0181241","volume":"12","author":"Attia M.I.","year":"2017","unstructured":"Attia M.I.; Eldehna W.M.; Afifi S.A.; Keeton A.B.; Piazza G.A.; Abdel-Aziz H.A.; New hydrazonoindolin-2-ones: Synthesis, exploration of the possible anti-proliferative mechanism of action and encapsulation into PLGA microspheres. PLoS One 2017,12(7),e0181241","journal-title":"PLoS One"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.2147\/DDDT.S140164","volume":"11","author":"Abdel-Aziz H.A.","year":"2017","unstructured":"Abdel-Aziz H.A.; Eldehna W.M.; Keeton A.B.; Piazza G.A.; Kadi A.A.; Attwa M.W.; Abdelhameed A.S.; Attia M.I.; Isatin-benzoazine molecular hybrids as potential antiproliferative agents: Synthesis and in vitro pharmacological profiling. Drug Des Devel Ther 2017,11,2333-2346","journal-title":"Drug Des Devel Ther"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/14756366.2018.1462802","volume":"33","author":"Eldehna W.M.","year":"2018","unstructured":"Eldehna W.M.; Al-Wabli R.I.; Almutairi M.S.; Keeton A.B.; Piazza G.A.; Abdel-Aziz H.A.; Attia M.I.; Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agents. J Enzyme Inhib Med Chem 2018,33(1),867-878","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gee.2019.03.002","volume":"5","author":"Qin H.","year":"2020","unstructured":"Qin H.; Hu X.; Wang J.; Cheng H.; Chen L.; Qi Z.; Overview of acidic deep eutectic solvents on synthesis, properties and applications. Green Energy and Environment 2020,5(1),8-21","journal-title":"Green Energy and Environment"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.fluid.2017.03.008","volume":"448","author":"Mjalli F.S.","year":"2017","unstructured":"Mjalli F.S.; Murshid G.; Al-Zakwani S.; Hayyan A.; Monoethanolamine-based deep eutectic solvents, their synthesis and characterization. Fluid Phase Equilib 2017,448,30-40","journal-title":"Fluid Phase Equilib"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.matlet.2016.02.065","volume":"171","author":"Karimi M.","year":"2016","unstructured":"Karimi M.; Eshraghi M.; Jahangir V.; A facile and green synthetic approach based on deep eutectic solvents toward synthesis of CZTS nanoparticles. Mater Lett 2016,171,100-103","journal-title":"Mater Lett"},{"key":"ref=63","author":"Doroshenko T.","year":"2011","unstructured":"Doroshenko T.; Samsoniya S.; Chikvaidze L.;  Bisindole derivatives: Synthesis of bis (1H-indol-5-yl) methane new derivatives LAP 2011","journal-title":"Bisindole derivatives: Synthesis of bis (1H-indol-5-yl) methane new derivatives LAP"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s11164-011-0479-4","volume":"38","author":"Azizi N.","year":"2012","unstructured":"Azizi N.; Manocheri Z.; Eutectic salts promote green synthesis of bis (indolyl) methanes. Res Chem Intermed 2012,38(7),1495-1500","journal-title":"Res Chem Intermed"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"28597","DOI":"10.1039\/C5RA02906F","volume":"5","author":"Ganesan A.","year":"2015","unstructured":"Ganesan A.; Kothandapani J.; Nanubolu J.B.; Ganesan S.S.; Oleic acid: A benign Br&#xF8;nsted acidic catalyst for densely substituted indole derivative synthesis. RSC Advances 2015,5(36),28597-28600","journal-title":"RSC Advances"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1021\/cr100162c","volume":"110","author":"Butler R.N.","year":"2010","unstructured":"Butler R.N.; Coyne A.G.; Water: Nature\u2019s reaction enforcer--comparative effects for organic synthesis &#x201C;in-water&#x201D; and &#x201C;on-water&#x201D;. Chem Rev 2010,110(10),6302-6337","journal-title":"Chem Rev"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1021\/la030160z","volume":"20","author":"Kamogawa K.","year":"2004","unstructured":"Kamogawa K.; Okudaira G.; Matsumoto M.; Sakai T.; Sakai H.; Abe M.; Preparation of oleic acid\/water emulsions in surfactant-free condition by sequential processing using midsonic-megasonic waves. Langmuir 2004,20(6),2043-2047","journal-title":"Langmuir"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"103929","DOI":"10.1016\/j.bioorg.2020.103929","volume":"100","author":"Karadayi F.Z.","year":"2020","unstructured":"Karadayi F.Z.; Yaman M.; Kisla M.M.; Keskus A.G.; Konu O.; Ates-Alagoz Z.; Design, synthesis and anticancer\/antiestrogenic activities of novel indole-benzimidazoles. Bioorg Chem 2020,100,103929","journal-title":"Bioorg Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1747-0285.2012.01442.x","volume":"80","author":"Ates-Alagoz Z.","year":"2012","unstructured":"Ates-Alagoz Z.; Coleman N.; Martin M.; Wan A.; Adejare A.; Syntheses and in vitro anticancer properties of novel radiosensitizers. Chem Biol Drug Des 2012,80(6),853-861","journal-title":"Chem Biol Drug Des"},{"key":"ref=70","first-page":"565","volume":"1","author":"Walia R.","year":"2011","unstructured":"Walia R.; Hedaitullah M.; Naaz S.F.; Iqbal K.; Lamba H.; Benzimidazole derivatives-an overview. Int J Res Pharm Chem 2011,1(3),565-574","journal-title":"Int J Res Pharm Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/14756360500131706","volume":"20","author":"Ate&#x15F;-Alag&#xF6;z Z.","year":"2005","unstructured":"Ate&#x15F;-Alag&#xF6;z Z.; Ku&#x15F; C.; &#xC7;oban T.; Synthesis and antioxidant properties of novel benzimidazoles containing substituted indole or 1,1,4,4-tetramethyl-1,2,3,4-tetrahydro-naphthalene fragments. J Enzyme Inhib Med Chem 2005,20(4),325-331","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"111691","DOI":"10.1016\/j.ejmech.2019.111691","volume":"183","author":"Wan Y.","year":"2019","unstructured":"Wan Y.; Li Y.; Yan C.; Yan M.; Tang Z.; Indole: A privileged scaffold for the design of anti-cancer agents. Eur J Med Chem 2019,183,111691","journal-title":"Eur J Med Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ejmech.2012.06.047","volume":"55","author":"Kumar D.","year":"2012","unstructured":"Kumar D.; Kumar N.M.; Noel B.; Shah K.; A series of 2-arylamino-5-(indolyl)-1,3,4-thiadiazoles as potent cytotoxic agents. Eur J Med Chem 2012,55,432-438","journal-title":"Eur J Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejmech.2018.02.065","volume":"150","author":"Dadashpour S.","year":"2018","unstructured":"Dadashpour S.; Emami S.; Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms. Eur J Med Chem 2018,150,9-29","journal-title":"Eur J Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.cr.7310149","volume":"17","author":"Gallinari P.","year":"2007","unstructured":"Gallinari P.; Di Marco S.; Jones P.; Pallaoro M.; Steink&#xFC;hler C.; HDACs, histone deacetylation and gene transcription: From molecular biology to cancer therapeutics. Cell Res 2007,17(3),195-211","journal-title":"Cell Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"e22739","DOI":"10.1371\/journal.pone.0022739","volume":"6","author":"Cea M.","year":"2011","unstructured":"Cea M.; Soncini D.; Fruscione F.; Raffaghello L.; Garuti A.; Emionite L.; Moran E.; Magnone M.; Zoppoli G.; Reverberi D.; Caffa I.; Salis A.; Cagnetta A.; Bergamaschi M.; Casciaro S.; Pierri I.; Damonte G.; Ansaldi F.; Gobbi M.; Pistoia V.; Ballestrero A.; Patrone F.; Bruzzone S.; Nencioni A.; Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. PLoS One 2011,6(7),e22739","journal-title":"PLoS One"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejmech.2019.02.032","volume":"168","author":"Chen X.","year":"2019","unstructured":"Chen X.; Zhao S.; Li H.; Wang X.; Geng A.; Cui H.; Lu T.; Chen Y.; Zhu Y.; Design, synthesis and biological evaluation of novel isoindolinone derivatives as potent histone deacetylase inhibitors. Eur J Med Chem 2019,168,110-122","journal-title":"Eur J Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1586\/14737140.2015.1047770","volume":"15","author":"Richardson P.G.","year":"2015","unstructured":"Richardson P.G.; Laubach J.P.; Lonial S.; Moreau P.; Yoon S-S.; Hungria V.T.; Dimopoulos M.A.; Beksac M.; Alsina M.; San-Miguel J.F.; Panobinostat: A novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma. Expert Rev Anticancer Ther 2015,15(7),737-748","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1158\/0008-5472.CAN-08-3365","volume":"69","author":"Liu T.","year":"2009","unstructured":"Liu T.; Liu P.Y.; Marshall G.M.; The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res 2009,69(5),1702-1705","journal-title":"Cancer Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.7150\/ijbs.13833","volume":"12","author":"Park E.Y.","year":"2016","unstructured":"Park E.Y.; Woo Y.; Kim S.J.; Kim D.H.; Lee E.K.; De U.; Kim K.S.; Lee J.; Jung J.H.; Ha K-T.; Choi W.S.; Kim I.S.; Lee B.M.; Yoon S.; Moon H.R.; Kim H.S.; Anticancer effects of a new SIRT inhibitor, MHY2256, against human breast cancer MCF-7 cells via regulation of MDM2-p53 binding. Int J Biol Sci 2016,12(12),1555-1567","journal-title":"Int J Biol Sci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1039\/c1md00029b","volume":"2","author":"Layek M.","year":"2011","unstructured":"Layek M.; Kumar Y.S.; Islam A.; Karavarapu R.; Sengupta A.; Halder D.; Mukkanti K.; Pal M.; Alkynylation of N-(3-iodopyridin-2-yl) sulfonamide under Pd\/C\u2013Cu catalysis: A direct one pot synthesis of 7-azaindoles and their pharmacological evaluation as potential inhibitors of sirtuins. MedChemComm 2011,2(6),478-485","journal-title":"MedChemComm"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.bmcl.2012.12.089","volume":"23","author":"Rambabu D.","year":"2013","unstructured":"Rambabu D.; Raja G.; Yogi Sreenivas B.; Seerapu G.P.; Lalith Kumar K.; Deora G.S.; Haldar D.; Rao M.V.; Pal M.; Spiro heterocycles as potential inhibitors of SIRT1: Pd\/C-mediated synthesis of novel N-indolylmethyl spiroindoline-3,2\u2032-quinazolines. Bioorg Med Chem Lett 2013,23(5),1351-1357","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ejmech.2018.01.076","volume":"146","author":"Wan Y.","year":"2018","unstructured":"Wan Y.; Dai N.; Tang Z.; Fang H.; Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents. Eur J Med Chem 2018,146,471-482","journal-title":"Eur J Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"Czabotar P.E.","year":"2014","unstructured":"Czabotar P.E.; Lessene G.; Strasser A.; Adams J.M.; Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy. Nat Rev Mol Cell Biol 2014,15(1),49-63","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature09779","volume":"471","author":"Wertz I.E.","year":"2011","unstructured":"Wertz I.E.; Kusam S.; Lam C.; Okamoto T.; Sandoval W.; Anderson D.J.; Helgason E.; Ernst J.A.; Eby M.; Liu J.; Belmont L.D.; Kaminker J.S.; O\u2019Rourke K.M.; Pujara K.; Kohli P.B.; Johnson A.R.; Chiu M.L.; Lill J.R.; Jackson P.K.; Fairbrother W.J.; Seshagiri S.; Ludlam M.J.; Leong K.G.; Dueber E.C.; Maecker H.; Huang D.C.; Dixit V.M.; Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 2011,471(7336),110-114","journal-title":"Nature"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1021\/acs.jmedchem.5b01888","volume":"60","author":"Yap J.L.","year":"2017","unstructured":"Yap J.L.; Chen L.; Lanning M.E.; Fletcher S.; Expanding the Cancer Arsenal with Targeted Therapies: Disarmament of the antiapoptotic Bcl-2 proteins by small molecules: Miniperspective. J Med Chem 2017,60(3),821-838","journal-title":"J Med Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1021\/jm301448p","volume":"56","author":"Friberg A.","year":"2013","unstructured":"Friberg A.; Vigil D.; Zhao B.; Daniels R.N.; Burke J.P.; Garcia-Barrantes P.M.; Camper D.; Chauder B.A.; Lee T.; Olejniczak E.T.; Fesik S.W.; Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design. J Med Chem 2013,56(1),15-30","journal-title":"J Med Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejmech.2019.03.050","volume":"172","author":"Asati V.","year":"2019","unstructured":"Asati V.; Mahapatra D.K.; Bharti S.K.; PIM kinase inhibitors: Structural and pharmacological perspectives. Eur J Med Chem 2019,172,95-108","journal-title":"Eur J Med Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrc2986","volume":"11","author":"Nawijn M.C.","year":"2011","unstructured":"Nawijn M.C.; Alendar A.; Berns A.; For better or for worse: The role of Pim oncogenes in tumorigenesis. Nat Rev Cancer 2011,11(1),23-34","journal-title":"Nat Rev Cancer"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ejmech.2019.03.025","volume":"171","author":"Naaz F.","year":"2019","unstructured":"Naaz F.; Haider M.R.; Shafi S.; Yar M.S.; Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains. Eur J Med Chem 2019,171,310-331","journal-title":"Eur J Med Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/cbdd.12616","volume":"86","author":"Hu M.J.","year":"2015","unstructured":"Hu M.J.; Zhang B.; Yang H.K.; Liu Y.; Chen Y.R.; Ma T.Z.; Lu L.; You W.W.; Zhao P.L.; Design, synthesis and molecular docking studies of novel indole\u2013pyrimidine hybrids as tubulin polymerization inhibitors. Chem Biol Drug Des 2015,86(6),1491-1500","journal-title":"Chem Biol Drug Des"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.tips.2010.08.007","volume":"31","author":"Su T-P.","year":"2010","unstructured":"Su T-P.; Hayashi T.; Maurice T.; Buch S.; Ruoho A.E.; The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol Sci 2010,31(12),557-566","journal-title":"Trends Pharmacol Sci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bbrc.2017.07.136","volume":"491","author":"Bai T.","year":"2017","unstructured":"Bai T.; Wang S.; Zhao Y.; Zhu R.; Wang W.; Sun Y.; Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells. Biochem Biophys Res Commun 2017,491(4),919-925","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.1021\/jm301545c","volume":"56","author":"Mach R.H.","year":"2013","unstructured":"Mach R.H.; Zeng C.; Hawkins W.G.; The &#x3C3;2 receptor: A novel protein for the imaging and treatment of cancer. J Med Chem 2013,56(18),7137-7160","journal-title":"J Med Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"9012","DOI":"10.3390\/ijms21239012","volume":"21","author":"Cortesi M.","year":"2020","unstructured":"Cortesi M.; Zamagni A.; Pignatta S.; Zanoni M.; Arienti C.; Rossi D.; Collina S.; Tesei A.; Pan-Sigma Receptor Modulator RC-106 Induces Terminal Unfolded Protein Response In In Vitro Pancreatic Cancer Model. Int J Mol Sci 2020,21(23),9012","journal-title":"Int J Mol Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1747-0285.2011.01215.x","volume":"78","author":"Yarim M.","year":"2011","unstructured":"Yarim M.; Koksal M.; Schepmann D.; W&#xFC;nsch B.; Synthesis and in vitro evaluation of novel indole\u2010based sigma receptors ligands. Chem Biol Drug Des 2011,78(5),869-875","journal-title":"Chem Biol Drug Des"}],"container-title":["Current Organic Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570179419666220509215722","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204499\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570179419666220509215722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:17:51Z","timestamp":1679962671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204499\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570179419666220509215722","relation":{},"ISSN":["1570-1794"],"issn-type":[{"value":"1570-1794","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-01-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}